Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10211499 | Saudi Journal of Ophthalmology | 2018 | 5 Pages |
Abstract
Cyclosporine A ophthalmic emulsion 0.05% has been demonstrated to be effective and safe in human clinical trials. It reduces signs and symptoms of dry eye disease, with the fact that its effect continued to occur significantly within the treatment periods as well as improvement of ocular condition kept on, actually more slowly towards stability, despite the drug has already stopped.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Tageldin M. Othman, Ahmed Mousa, Priscilla W. Gikandi, Mohamed AbdelMabod, Ahmed M. Abdelrahman,